The role of community pharmacies in early detection of suspected COVID-19 cases in 2020: lessons from Dar es Salaam, Tanzania

Tanzania reported its first COVID-19 case on 16 March 2020. We conducted event-based surveillance of COVID-19 suspect cases among pharmacy clients presenting with respiratory symptoms and influenza-like illness to increase early and rapid detection of COVID-19 cases and mitigate transmission. We conveniently sampled 103 pharmacies from Dar es Salaam, the epicentre for the COVID-19 pandemic in Tanzania at the time. Between 23 April 2020 and 18 May 2020, 67% of the pharmacies (69/103) reported an observed increase in the number of clients presenting with respiratory symptoms and influenza-like illness compared with the 1 month before the COVID-19 outbreak. In the 1-month surveillance period, the participating pharmacies recorded 75 alerts of COVID-19 suspect cases and referred all suspected COVID-19 cases to rapid response teams for additional symptomatic screening and SARS-CoV-2 testing. A key implementation challenge was that some clients identified as COVID-19 suspected cases were hesitant to provide follow-up information for linkage to rapid response teams. Addressing concerns among drug dispensers in the participating pharmacies and informing them of the benefits of the surveillance activity were important implementation components. Our approach demonstrates the overall feasibility of rapidly implementing an event-based surveillance system for an emerging health threat through an existing network of pharmacies within the community. The approach and tools used in this surveillance activity could be adapted in similar settings to detect and generate alerts of disease outbreaks in the community that other surveillance systems may otherwise miss.

[1]  Federico Germani,et al.  WHO and digital agencies: how to effectively tackle COVID-19 misinformation online , 2022, BMJ Global Health.

[2]  K. Jamieson,et al.  The Covid-19 Infodemic - Applying the Epidemiologic Model to Counter Misinformation. , 2021, The New England journal of medicine.

[3]  M. Lovegrove,et al.  Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by US Retail Pharmacies During the Pandemic. , 2021, JAMA internal medicine.

[4]  A. Güemes,et al.  A syndromic surveillance tool to detect anomalous clusters of COVID-19 symptoms in the United States , 2020, Scientific Reports.

[5]  D. Ekouevi,et al.  Assessment of self-medication practices in the context of COVID-19 outbreak in Togo , 2020 .

[6]  R. Mfune,et al.  Self-medication and its Consequences during & after the Coronavirus Disease 2019 (COVID-19) Pandemic: A Global Health Problem , 2020, European Journal of Environment and Public Health.

[7]  L. Wee,et al.  Utilizing the electronic health records to create a syndromic staff surveillance system during the COVID-19 outbreak , 2020, American Journal of Infection Control.

[8]  Alimuddin Zumla,et al.  Lockdown measures in response to COVID-19 in nine sub-Saharan African countries , 2020, BMJ Global Health.

[9]  M. Mahande,et al.  Community engagement in COVID-19 prevention: experiences from Kilimanjaro region, Northern Tanzania , 2020, The Pan African medical journal.

[10]  D. Onchonga,et al.  Assessing the prevalence of self-medication among healthcare workers before and during the 2019 SARS-CoV-2 (COVID-19) pandemic in Kenya , 2020, Saudi Pharmaceutical Journal.

[11]  M. Kazaura,et al.  Prevalence and Factors Associated with Parents Self-Medicating Under-Fives with Antibiotics in Bagamoyo District Council, Tanzania: a Cross-Sectional Study , 2020, Patient preference and adherence.

[12]  Jeri Albano,et al.  The use of IV vitamin C for patients with COVID-19: a case series , 2020, Expert review of anti-infective therapy.

[13]  D. Onchonga A Google Trends study on the interest in self-medication during the 2019 novel coronavirus (COVID-19) disease pandemic , 2020, Saudi Pharmaceutical Journal.

[14]  Mark Dredze,et al.  Internet Searches for Unproven COVID-19 Therapies in the United States. , 2020, JAMA internal medicine.

[15]  H. Li,et al.  YouTube as a source of information on COVID-19: a pandemic of misinformation? , 2020, BMJ Global Health.

[16]  B. Cowling,et al.  Rational use of face masks in the COVID-19 pandemic , 2020, The Lancet Respiratory Medicine.

[17]  J. Chilongola,et al.  Prevalence, determinants and knowledge of antibacterial self-medication: A cross sectional study in North-eastern Tanzania , 2018, PloS one.

[18]  D. Ross-Degnan,et al.  Understanding the Role of Accredited Drug Dispensing Outlets in Tanzania’s Health System , 2016, PloS one.

[19]  H. Sillo,et al.  Accrediting retail drug shops to strengthen Tanzania’s public health system: an ADDO case study , 2015, Journal of pharmaceutical policy and practice.

[20]  H. Campbell,et al.  The Recognition of and Care Seeking Behaviour for Childhood Illness in Developing Countries: A Systematic Review , 2014, PloS one.

[21]  D. Ross-Degnan,et al.  Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. , 2011, Health policy.

[22]  Emmanuel Alphonce,et al.  Creating a New Class of Pharmaceutical Services Provider for Underserved Areas: The Tanzania Accredited Drug Dispensing Outlet Experience , 2009, Progress in community health partnerships : research, education, and action.